Furthermore, these studies suggest that immune modulation with medications such as anti-IgE, anti-IL-4, and/or IL-13 monoclonal antibodies may be helpful in the treatment of ABPA. Here, IL13 is linked to allergic bronchopulmonary aspergillosis.